USA 11:00 am EDT, 8:00 am PDT, 16:00 BST
In the treatment of many diseases, decisions are based on the analysis of tissue. The tissue is traditionally analyzed by microscopic and/or molecular techniques that require labels or probes. Mass spectrometric imaging allows to analyze tissue directly without molecular labels. It therefore allows discovery approaches. One can also correlate mass spectrometric phenotypes to disease states. In this webinar, Dr Ron Heeren presents his approach for translational MALDI imaging research in close collaboration with clinicians to predict disease states based on mass spectrometric tissue typing.
A limiting factor in clinical MALDI imaging research so far has been the throughput of commercially available MALDI instruments. New developments on the instrumentation side will be presented that allow to increase the throughput and speed of the measurements by more than an order of magnitude. This increase in speed will be discussed in the context of large scale clinical studies on tissue.
- MALDI imaging for tissue typing in clinical research on personalized medicine
- New MALDI instrumentation for increasing throughput and robustness by at least an order of magnitude